Roberto is an experienced technology business leader and operator. He is currently deployed as CEO of Brandprotect, where he engineered the turn-around of the core business from declining revenues to 75% year-over-year growth. He also serves as the CEO of Nulogx, a leading canadian transportation management solutions company and publisher of the Canadian General Freight Index.
Prior to joining Brandimensions, Roberto founded DME Consulting Inc., a management consulting firm specializing in strategy and M&A. Clients include Corel Corporation, AOL Canada, and BCE, where DME advised on several acquisitions with aggregate revenues north of $200 million.
Prior to DME Consulting, Roberto served as CEO for SoftQuad Software Ltd., a company he acquired through a management buy-out and subsequently took public both in the U.S. and Canada. Previously, Roberto was president of Carolian Systems, a network management software solutions company.
Elias is the Chairman and founder of Greybrook a private equity firm focused on Real Estate and Healthcare.
Elias is also Chairman of Greenbrook TMS NeuroHealth Centers (TSX: GTMS), the leading provider of TMS Therapy in North America. Greenbrook clinics provide a novel treatment for patients suffering with depression. He is also chairman of TearLab Corporation (NASDAQ/TEAR, TSX TLB), an ophthalmic device company developing and commercializing novel, lab-on-a-chip technologies that enable eye care practitioners to test for highly sensitive and specific biomarkers in tears at the point-of-care.
Prior to Greybrook, Elias co-founded TLCVision (NASDAQ/TLCV, TSX/TLC) where he served as President and CEO.
Elias, as CEO, built TLC into the largest eye care service provider organization in North America with revenues of more than $300,000,000 as TLC opened or acquired more than 100 laser eye clinics, over 200 mobile laser sites, more than 250 mobile cataract locations several ambulatory surgery centers and through its subsidiary Vision Source Inc. developed the largest independent Optometric Franchise with more than 2,000 locations.
TLC’s stock, listed on the TSX and NASDAQ since 1996, appreciated to well over $1 Billion during his tenure.
Elias has received many management awards from industry and his peers including.
Sasha is an experienced private equity professional. As the CEO of Greybrook Securities, he directs Greybrook’s capital markets activities across the firm’s focus areas in real estate and healthcare. Sasha has completed over 50 acquisitions throughout the Greybrook portfolio and has been instrumental in expanding Greybrook’s roster of high net worth and institutional clients globally. Operationally, Sasha co-manages Greybrook Realty Partners’ business across both its Asset Management and Capital Markets verticals. His deep understanding of both operations and the capital markets has proven to be invaluable in leading the firm’s evaluation of prospective investments.
Sasha serves as the co-chair of Greybrook’s advisory committee for all active limited partnerships, and the co-chair of Greybrook’s investment committee, which to date has managed $1 billion of investor equity, deployed across 60+ real estate development projects with an estimated completion value of more than $14 billion CAD.
As the former CEO of Greybrook Health, Sasha played a critical role in the launch of Greenbrook TMS (TSX: GTMS) and Greybrook’s prior portfolio acquisitions of MacuHealth and Bruder Health Care. He currently serves on the board of Greenbrook TMS, as well as on the boards of a number of Greybrook affiliated companies and the Blu Genes Foundation, a charity dedicated to funding the advancement of the science of gene therapy for the treatment of various genetic disorders.
After receiving a B.A. in Economics from York University in 2000, Sasha went on to play professional hockey for three seasons. Following this, he began his career at TD Securities and CIBC before moving on to start Greybrook Capital with his partners Elias Vamvakas and Peter Politis.
Peter is a partner at Greybrook Capital, a North American private equity firm, and the CEO of Greybrook Realty Partners, a leading real estate asset management firm with over a $1 billion in equity invested in real estate developments across Southern Ontario and South Florida.
He is co-chair of Greybrook Realty’s Investment Committee and leads the firm’s deal origination and asset management practice. In his capacity as CEO, he has been involved in the acquisition of over 50 developments representing 32 million square feet of density and an aggregate completion value of over $14 billion.
Peter also plays a critical role in the success of Greybrook Capital’s portfolio companies, serving on the boards of a number of Greybrook affiliated companies. He also serves on the board of Blu Genes Foundation, a charity funding the advancement of gene therapy sciences for the treatment of various genetic disorders.